Indocyanine Green Test in Bariatric Surgery

NCT05476159 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-07-27

No results posted yet for this study

Summary

Indocyanine green (ICG) can be injected into the human bloodstream and it allows us to show stomach vascularity in real time

Conditions

  • Obesity, Morbid
  • Surgery
  • Leak, Anastomotic

Interventions

DRUG

Indocyanine green solution

Adequate perfusion was defined as "the direct and clear visualization of the fluorescence along the gastric tube, relative to the excised specimen, after an estimated time of 150-180 s after i.v. administration injection

DEVICE

Gastric bypass

Roux and Y Gastric bypass

Sponsors & Collaborators

  • University of Foggia

    lead OTHER

Principal Investigators

  • Giovanna Pavone · University of Foggia

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-11-01
Completion
2021-12-31
FDA Drug
Yes
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476159 on ClinicalTrials.gov